News
In those nations, MAID is available to a wider universe of pained people, not just those with fewer than six months to live.
49m
InvestorsHub on MSNNiagen Bioscience Shares Climb Following Exclusive License for Parkinson’s TherapyNiagen Bioscience Inc. (NASDAQ:NAGE) saw its stock rise 2% after securing an exclusive global commercial license from Norway’s Haukeland University Hospital to develop its nicotinamide riboside ...
Video. A unique programme in Rio de Janeiro is helping people with Parkinson’s disease manage their symptoms through the art of capoeira.
A neglected piece of the Alzheimer's puzzle has been getting increased scientific attention: why women are twice as likely as ...
Because Alzheimer’s is just one of several diseases that cause dementia, the key distinction lies in their scope.
A new drug originally developed to treat a different brain disease is now showing signs that it could help people with ...
Parkinson’s Disease Support Group: 2 p.m. meeting at Sanford Health WindSong in Bemidji, open to anyone with Parkinson’s ...
New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...
Parkinson’s disease often starts on one side of the body, and new research shows this asymmetry influences how non-motor symptoms progress.
A collaborative study led by Professor Vittoria Raffa at the University of Pisa and Assistant Professor Fabian Raudzus ...
Ambroxol, a cough medication, may help stabilize the neuropsychiatric symptoms of Parkinson's disease dementia, a new study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results